Severe psoriasis in a 3-year-old child treated with methotrexate.

Authors

  • R. Baswedan
  • A.N. Hidayati
  • Y. Widia
  • Sawitri
  • S. Suyoso

DOI:

https://doi.org/10.26326/2281-9649.36.1.2886

Keywords:

psoriasis, child, methotrexate

Abstract

Psoriasis vulgaris in early childhood is uncommon and may present diagnostic challenges, particularly when clinical features mimic other inflammatory dermatoses. We report a 3-year-old boy with widespread erythematous, scaly plaques involving the scalp, face, trunk, extremities, and inguinal region, accompanied by obesity as a relevant comorbidity. Histopathological examination confirmed psoriasis vulgaris, and methotrexate was initiated at 0.3 mg/kg/week with folic acid supplementation. Progressive clinical improvement was observed within the first month, and near-complete resolution of lesions occurred after two months, without adverse effects or laboratory abnormalities. This case highlights methotrexate as an effective and well-tolerated systemic option for moderate-to-severe pediatric psoriasis, particularly in resource-limited settings or when comorbid obesity is present.

Published

2026-02-01

How to Cite

Baswedan, R., Hidayati, A., Widia, Y., Sawitri, & Suyoso, S. (2026). Severe psoriasis in a 3-year-old child treated with methotrexate. European Journal of Pediatric Dermatology, 36(1), 61–4. https://doi.org/10.26326/2281-9649.36.1.2886

Issue

Section

Letters to the Editor